HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells.

Abstract
Histone deacetylase inhibitors (HDACIs) are promising antineoplastic agents for the treatment of cancer. Here we report that the lipid peroxidation end product 4-hydroxynonenal (HNE) significantly potentiates the anti-tumor effects of the HDAC inhibitor panobinostat (LBH589) in the PC3 prostate cancer cell model. Panobinostat and HNE inhibited proliferation of PC3 cells and the combination of the two agents resulted in a significant combined effect. Cell cycle analysis revealed that both single agents and, to a greater extent, their combined treatment induced G2/M arrest, but cell death occurred in the combined treatment only. Furthermore, HNE and, to a greater extent, the combined treatment induced dephosphorylation of Cdc2 leading to progression into mitosis as confirmed by α-tubulin/DAPI staining and phospho-histone H3 (Ser10) analysis. To evaluate possible induction of DNA damage we utilized the marker phosphorylated histone H2A.X. Results showed that the combination of panobinostat and HNE induced significant DNA damage concomitant with the mitotic arrest. Then, by using androgen receptor (AR)-expressing PC3 cells we observed that the responsiveness to HNE and panobinostat was independent of the expression of functional AR. Taken together, our data suggest that HNE potentiates the antitumoral effect of the HDACI panobinostat in prostate cancer cells.
AuthorsPiergiorgio Pettazzoni, Stefania Pizzimenti, Cristina Toaldo, Paula Sotomayor, Luigina Tagliavacca, Song Liu, Dan Wang, Rosalba Minelli, Leigh Ellis, Peter Atadja, Eric Ciamporcero, Mario Umberto Dianzani, Giuseppina Barrera, Roberto Pili
JournalFree radical biology & medicine (Free Radic Biol Med) Vol. 50 Issue 2 Pg. 313-22 (Jan 15 2011) ISSN: 1873-4596 [Electronic] United States
PMID21078383 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Elsevier Inc. All rights reserved.
Chemical References
  • AR protein, human
  • Aldehydes
  • Cysteine Proteinase Inhibitors
  • H2AX protein, human
  • Histone Deacetylase Inhibitors
  • Histones
  • Hydroxamic Acids
  • Indoles
  • Receptors, Androgen
  • Panobinostat
  • Glutathione
  • 4-hydroxy-2-nonenal
Topics
  • Acetylation
  • Aldehydes (pharmacology)
  • Apoptosis (drug effects)
  • Blotting, Western
  • Cell Cycle (drug effects)
  • Cysteine Proteinase Inhibitors (pharmacology)
  • DNA Damage (drug effects)
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • Glutathione (metabolism)
  • Histone Deacetylase Inhibitors (pharmacology)
  • Histones (antagonists & inhibitors, metabolism)
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Indoles
  • Lipid Peroxidation (drug effects)
  • Male
  • Panobinostat
  • Phosphorylation (drug effects)
  • Prostatic Neoplasms (drug therapy, metabolism, pathology)
  • Receptors, Androgen (metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: